These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18056265)

  • 1. Activin A/bone morphogenetic protein (BMP) chimeras exhibit BMP-like activity and antagonize activin and myostatin.
    Korupolu RV; Muenster U; Read JD; Vale W; Fischer WH
    J Biol Chem; 2008 Feb; 283(7):3782-90. PubMed ID: 18056265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An activin-A/C chimera exhibits activin and myostatin antagonistic properties.
    Muenster U; Harrison CA; Donaldson C; Vale W; Fischer WH
    J Biol Chem; 2005 Nov; 280(44):36626-32. PubMed ID: 16129674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competition between type I activin and BMP receptors for binding to ACVR2A regulates signaling to distinct Smad pathways.
    Szilágyi SS; Amsalem-Zafran AR; Shapira KE; Ehrlich M; Henis YI
    BMC Biol; 2022 Feb; 20(1):50. PubMed ID: 35177083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
    Weber D; Kotzsch A; Nickel J; Harth S; Seher A; Mueller U; Sebald W; Mueller TD
    BMC Struct Biol; 2007 Feb; 7():6. PubMed ID: 17295905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An activin mutant with disrupted ALK4 binding blocks signaling via type II receptors.
    Harrison CA; Gray PC; Fischer WH; Donaldson C; Choe S; Vale W
    J Biol Chem; 2004 Jul; 279(27):28036-44. PubMed ID: 15123686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer.
    Tsuchida K; Nakatani M; Uezumi A; Murakami T; Cui X
    Endocr J; 2008 Mar; 55(1):11-21. PubMed ID: 17878607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of BMP-9 and functional interactions with pro-region and receptors.
    Brown MA; Zhao Q; Baker KA; Naik C; Chen C; Pukac L; Singh M; Tsareva T; Parice Y; Mahoney A; Roschke V; Sanyal I; Choe S
    J Biol Chem; 2005 Jul; 280(26):25111-8. PubMed ID: 15851468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors.
    Olsen OE; Hella H; Elsaadi S; Jacobi C; Martinez-Hackert E; Holien T
    Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32235336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators.
    Souza TA; Chen X; Guo Y; Sava P; Zhang J; Hill JJ; Yaworsky PJ; Qiu Y
    Mol Endocrinol; 2008 Dec; 22(12):2689-702. PubMed ID: 18927237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells.
    Bondestam J; Kaivo-oja N; Kallio J; Groome N; Hydén-Granskog C; Fujii M; Moustakas A; Jalanko A; ten Dijke P; Ritvos O
    Mol Cell Endocrinol; 2002 Sep; 195(1-2):79-88. PubMed ID: 12354674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins.
    Sidis Y; Mukherjee A; Keutmann H; Delbaere A; Sadatsuki M; Schneyer A
    Endocrinology; 2006 Jul; 147(7):3586-97. PubMed ID: 16627583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic protein 2 and activin A synergistically stimulate follicle-stimulating hormone beta subunit transcription.
    Lee KB; Khivansara V; Santos MM; Lamba P; Yuen T; Sealfon SC; Bernard DJ
    J Mol Endocrinol; 2007 Feb; 38(1-2):315-30. PubMed ID: 17293449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a bone morphogenetic protein-responsive Smad-binding element.
    Kusanagi K; Inoue H; Ishidou Y; Mishima HK; Kawabata M; Miyazono K
    Mol Biol Cell; 2000 Feb; 11(2):555-65. PubMed ID: 10679014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibins differentially antagonize activin and bone morphogenetic protein action in a mouse adrenocortical cell line.
    Farnworth PG; Stanton PG; Wang Y; Escalona R; Findlay JK; Ooi GT
    Endocrinology; 2006 Jul; 147(7):3462-71. PubMed ID: 16601134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of FSHβ induction in LβT2 cells by BMP2 and an Activin A/BMP2 chimera, AB215.
    Jung JW; Ahn C; Shim SY; Gray PC; Kwiatkowski W; Choe S
    J Endocrinol; 2014 Oct; 223(1):35-45. PubMed ID: 25100748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An activin A/BMP2 chimera, AB204, displays bone-healing properties superior to those of BMP2.
    Yoon BH; Esquivies L; Ahn C; Gray PC; Ye SK; Kwiatkowski W; Choe S
    J Bone Miner Res; 2014 Sep; 29(9):1950-9. PubMed ID: 24692083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis.
    Rebbapragada A; Benchabane H; Wrana JL; Celeste AJ; Attisano L
    Mol Cell Biol; 2003 Oct; 23(20):7230-42. PubMed ID: 14517293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of bone morphogenetic protein-15 signaling in granulosa cells.
    Moore RK; Otsuka F; Shimasaki S
    J Biol Chem; 2003 Jan; 278(1):304-10. PubMed ID: 12419820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.